Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
AIDS and Behavior|June 10, 2011
Improving participant understanding of informed consent in an HIV-prevention clinical trial: a comparison of methodsAmy L Corneli, James R Sorenson, Margaret E Bentley, et al.Plos Medicine|January 27, 2011
Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studiesHaileyesus Getahun, Wanitchaya Kittikraisak, Charles M Heilig, et al.The New England Journal of Medicine|February 26, 2010
An algorithm for tuberculosis screening and diagnosis in people with HIVKevin P Cain, Kimberly D McCarthy, Charles M Heilig, et al.The Journal of Infectious Diseases|August 2, 2012
Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortiumSusan E Dorman, Stefan Goldberg, Jason E Stout, et al.Scientific Reports|December 27, 2024
Principal component analysis of the Serological response to Plasmodium Falciparum using a Multiplex bead-based assay in NigeriaJonathan S Schultz, Mary Okoli, Scott Lee, et al.JAMA Pediatrics|February 22, 2021
Sensitive and Feasible Specimen Collection and Testing Strategies for Diagnosing Tuberculosis in Young ChildrenRinn Song, Eleanor S Click, Kimberly D McCarthy, et al.American Journal of Respiratory and Critical Care Medicine|May 2, 2009
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosisSusan E Dorman, John L Johnson, Stefan Goldberg, et al.Contemporary Clinical Trials|April 1, 2021
Optimizing drug inventory management with a web-based information system: The TBTC Study 31/ACTG A5349 experienceNigel A Scott, Kara K Lee, Claire Sadowski, et al.American Journal of Respiratory and Critical Care Medicine|December 10, 2014
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trialSusan E Dorman, Radojka M Savic, Stefan Goldberg, et al.Contemporary Clinical Trials|January 26, 2020
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trialSusan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.Pageof 6